Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jonathan Ross Goodman Insider Profile
4 Followers
Jonathan Ross Goodman, Chairman, Ten Percent Owner at Knight Therapeutics, holds 22.54M shares in Knight Therapeutics (Ticker: KHTRF), holds 182.00K shares in Antibe Therapeutics (Ticker: ATBPF). Most recently, Jonathan Ross Goodman Bought ― shares of Knight Therapeutics on Sep 27, 2023 for an estimated value of 110.50K.
Jonathan Ross Goodman Knight Therapeutics (KHTRF)Chairman, Ten Percent Owner
Knight Therapeutics (KHTRF)
Chairman, Ten Percent Owner
Ranked #79,683 out of 105,977 Corporate Insiders
Profitable Transactions
9 out of 37 Profitable Transactions
Average Return
-5.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jonathan Ross Goodman holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jonathan Ross Goodman
Jonathan Ross Goodman's Trading History
Knight Therapeutics
Sep 27, 2023
Chairman, Ten Percent Owner
Informative Buy
110.50K
$87.69M
Antibe Therapeutics
Sep 02, 2013
Director
Informative Buy
100.10K
$101.19K
List of latest transactions for each holding click on a transaction to see Jonathan Ross Goodman's performance on stock
You May Also Like
Jonathan Ross Goodman insider profile FAQ
What is the percentage of profitable transactions made by Jonathan Ross Goodman?
The percentage of profitable transactions made by Jonathan Ross Goodman is 24%.
What is the average return per transaction made by Jonathan Ross Goodman?
The average return per transaction made by Jonathan Ross Goodman is -5.20%.
What stocks does Jonathan Ross Goodman hold?
Jonathan Ross Goodman holds: KHTRF, ATBPF stocks.
What was Jonathan Ross Goodman’s latest transaction?
Jonathan Ross Goodman latest transaction was an Informative Buy of $110.50K.
What was Jonathan Ross Goodman's most profitable transaction?
Jonathan Ross Goodman’s most profitable transaction was an Informative Buy of KHTRF stock on September 27, 2023. The return on the trade was 12.00%.
What is Jonathan Ross Goodman's role in Knight Therapeutics?
Jonathan Ross Goodman's role in Knight Therapeutics is Chairman, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.